Differential expression of heat shock protein 105 in melanoma and melanocytic naevi

Melanoma Research

Volumn 18, Issue 3, 2008, Pages 166-171

  Muchemwa, Faith Chengetayi ^a   Nakatsura, Tetsuya ^b   Fukushima, Satoshi ^a   Nishimura, Yasuharu ^a   Kageshita, Toshiro ^a   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Heat shock protein105; Melanocytic naevus; Melanoma

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 105;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; FEMALE; HSP110 HEAT-SHOCK PROTEINS; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS, PIGMENTED; PROGNOSIS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 43649089246     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3282fe9a16     Document Type: Article

References (13)

1. Honda K, Hatayama T, Yukioka M. Common antigenicity of mouse 42 degrees C-specific heat shock protein with mouse HSP105. Biochem Biophys Res Commun. 1989; 160:60-66.
2. Hatayama T, Nishiyama E, Yasuda K. Cellular localization of high-molecularmass heat shock protein in murine cells. Biochem Biophys Res Commun 1994; 200:1367-1373.
3. Hosaka S, Nakatsura T, Tsukamoto H, Hatayama T, Baba H, Nishimura Y. Synthetic small interfering RNA targeting heat shock protein 105 induces apoptosis of various cancer cells both in vitro and in vivo. Cancer Sci 2006; 97:623-632.
4. Yamagishi N, Ishihara K, Saito Y, Hatayama Y. Hsp105 family proteins suppress staurosporine-induced apoptosis by inhibiting the translocation of Bax to mitochondria in HeLa cells. Exp Cell Res 2007; 312:3215-3223.
5. Muchemwa FC, Nakatsura T, Ihn H, Kageshita T. HSP105 is overexpressed in squamous cell carcinoma and extramammary Paget's disease but not in basal cell carcinoma. Brit J Derm 2006; 155:582-585.
6. Kai M, Nakatsura T, Egami H, Senju S, Nishimura Y, Ogawa M. Heat shock protein 105 is overexpressed in a variety of human tumors. Oncol Rep 2003; 10:1777-1782.
7. Balch CM, Soong S, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, et al. An evidence-based staging system for cutaneous melanoma. Ca Cancer J Clin 2004; 54:131-149.
8. Parmiami G, Testori A, Maio M, Castelli C, Rivoltini L, Pilla L. Heat shock proteins and their use as cancer vaccines. Clin Cancer Res 2004; 10:8142-8146.
9. Yamagishi N, Ishihara K, Saito Y, Hatayama T. Hsp105 but not Hsp70 family proteins suppress the aggregation of heat-denatured protein in the presence of ADP. FEBS Lett 2003; 555:390-396.
10. Oh HJ, Chen X, Subjeck JR. Hsp110 protects heat-denatured proteins and confers cellular thermoresistence. J Biol Chem 1997; 272:31636- 31640.
11. + T cells. Cancer Sci 2005; 96:695-705.
12. Yokomine K, Nakatsura T, Minohara M, Kira J, Kubo T, Sasaki Y, et al. Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice. Biochem Biophys Res Commun 2006; 343:269-278.
13. Yokomine K, Nakatsura T, Senju S, Nakagata N, Minohara M, Kira J, et al. Regression of intestinal adenomas by vaccination with heat shock protein 105-pulsed denritic cells in Apc (Min/+) mice. Cancer Sci 2007; 98:1930-1935.